All Stories

  1. Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging
  2. Diffuse liver disease: the new horizon of multiparametric ultrasound
  3. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists
  4. Liver Fat Quantification With Ultrasound
  5. Interpreting shear wave elastography results in chronic hepatitis D virus infection
  6. Interpreting Liver Stiffness Values in Clinical Practice: Is Histologic Classification Necessary for Clinical Relevance?
  7. Quantification of Liver Fat Content with the iATT Algorithm: Correlation with Controlled Attenuation Parameter
  8. How to perform shear wave elastography. Part II
  9. US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative
  10. Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography
  11. How to perform shear wave elastography. Part I
  12. Update on the role of elastography in liver disease
  13. 2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting
  14. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper
  15. Beyond the AJR: “Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease”
  16. Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
  17. A model to predict liver damage in patients with HBeAg-positive chronic HBV infection
  18. What does liver elastography measure? Technical aspects and methodology
  19. Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
  20. CAP for the detection of hepatic steatosis in clinical practice
  21. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis
  22. Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study
  23. SIUMB recommendations for focal pancreatic lesions
  24. Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion
  25. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement
  26. Ultrasound liver elastography beyond liver fibrosis assessment
  27. Performance and cutoffs for liver fibrosis staging of a two-dimensional shear wave elastography technique
  28. Ultrasound-based techniques for the diagnosis of liver steatosis
  29. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique
  30. General advice in ultrasound based elastography of pediatric patients
  31. Point shear wave elastography by ElastPQ accurately stages hepatic fibrosis in patients with NAFLD: A prospective, multicentric study
  32. Ultrasound Techniques for the Assessment of Liver Stiffness: A Correct Terminology
  33. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations
  34. Review of Liver Elastography Guidelines
  35. Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment—A multicenter retrospective study
  36. Current Knowledge in Ultrasound-Based Liver Elastography of Pediatric Patients
  37. Evaluation of Inter-System Variability in Liver Stiffness Measurements
  38. Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
  39. Editorial: a novel technology for the assessment of non-alcoholic fatty liver disease
  40. Novel ultrasound-based methods to assess liver disease: The game has just begun
  41. Contrast-enhanced ultrasonography of the liver using SonoVue
  42. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis
  43. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
  44. Ruling-in and Ruling-out Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C Using a Shear Wave Measurement Method
  45. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
  46. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
  47. Limitations and artifacts in shear-wave elastography of the liver
  48. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
  49. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version)
  50. Shear wave elastography of the liver – review on normal values
  51. Ruling-in and ruling-out significant fibrosis and cirrhosis using a shear wave measurement method
  52. Impact of hepatic steatosis and controlled attenuation parameter (CAP) on accuracy of fibrosis staging using transient elastography
  53. The clinical value of the controlled attenuation parameter in the follow-up of HIV-infected patients
  54. Accuracy of the ElastPQ® Technique for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C: a “Real Life” Single Center Study
  55. The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis
  56. Elastography Assessment of Liver Fibrosis
  57. Liver stiffness assessed by transient elastography in patients with β thalassaemia major
  58. Accuracy of the latest release of a 2D shear wave elastography method for staging liver fibrosis in patients with chronic hepatitis C: Preliminary results
  59. Consensus on Elastography of the Liver
  60. Noninvasive Assessment of Liver Fibrosis and Steatosis in HIV-Monoinfected Subjects
  61. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection
  62. A Review of the Appropriateness of the Current Italian Guidelines for Noninvasive Imaging Assessment of Focal Liver Lesions
  63. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement
  64. Contrast enhanced ultrasound in the evaluation and percutaneous treatment of hepatic and renal tumors
  65. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast
  66. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver
  67. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 1: Basic Principles and Terminology
  68. O018 : 2D-shear wave elastography is equivalent or superior to transient elastography for liver fibrosis assessment: Results from an individual patient data based meta-analysis
  69. P1008 : Value of controlled attenuation parameter (CAP) in the clinical practice: preliminary results
  70. Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals
  71. Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis
  72. Ultrasound point shear wave elastography assessment of liver and spleen stiffness: effect of training on repeatability of measurements
  73. Shear Wave Elastography for Evaluation of Liver Fibrosis
  74. Point shear wave elastography method for assessing liver stiffness
  75. Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis
  76. Volume Responsiveness in Critically Ill Patients
  77. Real-time tissue elastography in the assessment of liver stiffness
  78. 16 PERFORMANCE OF ELASTPQ® SHEAR WAVE ELASTOGRAPHY TECHNIQUE FOR ASSESSING FIBROSIS IN CHRONIC VIRAL HEPATITIS
  79. Performance of liver stiffness measurements by transient elastography in chronic hepatitis
  80. Cat-scratch disease in Northern Italy: atypical clinical manifestations in humans and prevalence of Bartonella infection in cats
  81. Reproducibility of real-time shear wave elastography in the evaluation of liver elasticity
  82. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study
  83. Performance of Real-Time Strain Elastography, Transient Elastography, and Aspartate-to-Platelet Ratio Index in the Assessment of Fibrosis in Chronic Hepatitis C
  84. Assessment of liver stiffness with transient elastography by using S and M probes in healthy children
  85. 1052 PERFORMANCE OF REAL-TIME STRAIN ELASTOGRAPHY, SHEAR WAVE ELASTOGRAPHY, AND TRANSIENT ELASTOGRAPHY IN ASSESSING SIGNIFICANT FIBROSIS IN CHRONIC VIRAL HEPATITIS
  86. Arterial Stiffness Evaluation in HIV-Positive Patients: A Multicenter Matched Control Study
  87. Accuracy of Ultrasound Imaging Technique for Assessing Lipoatrophy in HIV-Infected Subjects
  88. Italian guidelines for noninvasive imaging assessment of focal liver lesions
  89. Retroperitoneal Cryptococcoma in a Case of Disseminated Cryptococcosis on Antifungal Maintenance Therapy
  90. Management of splenic abscess: report on 16 cases from a single center
  91. Follow-Up After Percutaneous Radiofrequency Ablation of Renal Cell Carcinoma: Contrast-Enhanced Sonography Versus Contrast-Enhanced CT or MRI
  92. Contrast-Enhanced Ultrasonographic Findings in a Brucellar Hepatic Abscess
  93. Titelbild - Große intrahepatische arterioportale Fistel nach Lebertrauma
  94. Percutaneous and surgical treatment of pyogenic liver abscesses: Observation over a 21-year period in 148 patients
  95. Comparability of Echographic and Tomographic Assessments of Body Fat Changes Related to the HIV Associated Adipose Redistribution Syndrome (HARS) in Antiretroviral Treated Patients
  96. Open Questions in the Assessment of Liver Fibrosis Using Real-Time Elastography
  97. Sonographic Training Program at a District Hospital in a Developing Country: Work in Progress
  98. Real-Time Elastography in the Assessment of Liver Fibrosis
  99. Percutaneous Needle Aspiration of Multiple Pyogenic Abscesses of the Liver: 13-Year Single-Center Experience
  100. Ärztliche Assistenz zur Selbsttötung - ethische, rechtliche und klinische Aspekte - Erwiderung
  101. The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations
  102. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy
  103. Liver Abscess Formation After Radiofrequency Ablation in Patients with Hepatocellular Carcinoma
  104. Contrast-Enhanced Low-Mechanical-Index Ultrasonography in Hepatic Splenosis
  105. Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center
  106. Contrast-Enhanced Sonographic Appearance of Hepatocellular Carcinoma in Patients with Cirrhosis: Comparison with Contrast-Enhanced Helical CT Appearance
  107. Radiofrequency Thermal Ablation versus Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma [letter]
  108. Acute Appendicitis Mimicking Infectious Enteritis
  109. Percutaneous Sonographically Guided Saline-Enhanced Radiofrequency Ablation of Hepatocellular Carcinoma
  110. Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery.
  111. Interobserver and interquipment variability of echo-doppler examination of the portal vein: Effect of a cooperative training program
  112. Interobserver and interequipment variability of echo-doppler examination of the portal vein: Effect of a cooperative training program
  113. Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: A double-blind randomized echo-doppler study
  114. Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: A double-blind randomized echo-doppler study*1
  115. Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study
  116. Operators, machines, and a time interval variability of Echo-Doppler flowmetry for splanchnic hemodynamics
  117. Echo-Doppler evaluation of acute flow changes in portal hypertensive patients: flow velocity as a reliable parameter
  118. A Randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients
  119. Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: An operator-blind echo-Doppler study
  120. Feasibility spectrum for Doppler flowmetry of splanchnic vessels. In normal and cirrhotic populations.
  121. Bile acids do not mediate the hyperdynamic circulation in portal hypertensive rats
  122. Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers